Voltage-activated K+ channels and membrane depolarization regulate accumulation of the cyclin-dependent kinase inhibitors p27(Kip1) and p21(CIP1) in glial progenitor cells

J Neurosci. 1999 Jul 1;19(13):5380-92. doi: 10.1523/JNEUROSCI.19-13-05380.1999.

Abstract

Neural cell development is regulated by membrane ion channel activity. We have previously demonstrated that cell membrane depolarization with veratridine or blockage of K+ channels with tetraethylammonium (TEA) inhibit oligodendrocyte progenitor (OP) proliferation and differentiation (); however the molecular events involved are largely unknown. Here we show that forskolin (FSK) and its derivative dideoxyforskolin (DFSK) block K+ channels in OPs and inhibit cell proliferation. The antiproliferative effects of TEA, FSK, DFSK, and veratridine were attributable to OP cell cycle arrest in G1 phase. In fact, (1) cyclin D accumulation in synchronized OP cells was not affected by K+ channel blockers or veratridine; (2) these agents prevented OP cell proliferation only if present during G1 phase; and (3) G1 blockers, such as rapamycin and deferoxamine, mimicked the anti-proliferative effects of K+ channel blockers. DFSK also prevented OP differentiation, whereas FSK had no effect. Blockage of K+ channels and membrane depolarization also caused accumulation of the cyclin-dependent kinase inhibitors p27(Kip1) and p21(CIP1) in OP cells. The antiproliferative effects of K+ channel blockers and veratridine were still present in OP cells isolated from INK4a-/- mice, lacking the cyclin-dependent kinase inhibitors p16(INK4a) and p19(ARF). Our results demonstrate that blockage of K+ channels and cell depolarization induce G1 arrest in the OP cell cycle through a mechanism that may involve p27(Kip1) and p21(CIP1) and further support the conclusion that OP cell cycle arrest and differentiation are two uncoupled events.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 8-Bromo Cyclic Adenosine Monophosphate / pharmacology
  • Animals
  • Cell Cycle Proteins*
  • Cell Division / drug effects
  • Cell Lineage / drug effects
  • Cerebellum / drug effects
  • Colforsin / analogs & derivatives
  • Colforsin / pharmacology
  • Cyclin D
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclin-Dependent Kinase Inhibitor p27
  • Cyclins / metabolism*
  • Deferoxamine / pharmacology
  • Ion Channel Gating / drug effects
  • Isoproterenol / pharmacology
  • Membrane Potentials* / drug effects
  • Mice
  • Microtubule-Associated Proteins / metabolism*
  • Oligodendroglia / cytology*
  • Oligodendroglia / drug effects
  • Oligodendroglia / metabolism
  • Potassium / metabolism
  • Potassium Channel Blockers
  • Potassium Channels / physiology*
  • Rats
  • Rats, Sprague-Dawley
  • Sirolimus / pharmacology
  • Stem Cells / cytology*
  • Stem Cells / drug effects
  • Stem Cells / metabolism
  • Tetraethylammonium / pharmacology
  • Tumor Suppressor Proteins*
  • Veratridine / pharmacology

Substances

  • Cdkn1a protein, mouse
  • Cdkn1a protein, rat
  • Cdkn1b protein, mouse
  • Cdkn1b protein, rat
  • Cell Cycle Proteins
  • Cyclin D
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • Microtubule-Associated Proteins
  • Potassium Channel Blockers
  • Potassium Channels
  • Tumor Suppressor Proteins
  • Cyclin-Dependent Kinase Inhibitor p27
  • Colforsin
  • 8-Bromo Cyclic Adenosine Monophosphate
  • Tetraethylammonium
  • Veratridine
  • Deferoxamine
  • Isoproterenol
  • 1,9-dideoxyforskolin
  • Potassium
  • Sirolimus